Interview with Kalyan Dulla, PhD, MBA
Kalyan Dulla, PhD, MBA Director Non-Clinical Research ProQR Therapeutics  How did you become interested in the field of oligonucleotides? Although I had been aware of the use of antisense oligonucleotides for (m)RNA knockdown or as aptamers since my university days I was not ...